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Correspondence116Author response to LiebergallWe thankMichal Liebergall for his comments on our systematic
review.1 As Liebergall indicates in his letter, there has already been
a similar debate on the same topic.2–4 We will repeat some of the
arguments here and also respond to new issues raised in the letter.
Liebergall argues that we have unfairly criticised his 2009 trial
by claiming that he did not conduct an intention-to-treat analysis
and by overstating the loss to follow-up. We stand by both claims.
The trial report5 includes a speciﬁc statement about post-
randomisation exclusions (page 380) and describes a secondary
analysis, which was intended to ‘approximate an intention to treat
analysis’. Leibergall suggests loss to follow-up was 27% instead of
28% because he calculated follow-up incorrectly by not including
in the denominator those subjects excluded after randomisation.
Either way – 27% or 28% – there is a very high rate of loss to follow-
up, which potentially threatens the validity of the trial’s
conclusions. We note that the trial was independently rated by
three trained raters for the PEDro web site and those raters also
concluded that the trial did not satisfy either the intention to treat
or adequate follow-up criterion.
Liebergall states that ‘the Paula method is based on the theory
that all sphincters in the body work together, and involves
rehabilitation of damagedmuscles by contraction and relaxation of
speciﬁc ring muscles in other areas of the body’. This is a theory
with no data to support it.6,7 Two independent research groups,
one from Norway and one from Brazil, with no knowledge of each
other’s studies and using different measurement methods
(transperineal ultrasound and vaginal surface electromyography),
have independently tested this hypothesis. Co-contraction of the
pelvic ﬂoor muscles (PFM) was not detected in either study.6,7 The
theory is therefore inconsistent with data from experimental
studies. Theories that cannot be reconciled with sound data should
be rejected.
Liebergall argues that the researchers who conducted the
experimental studies were not properly trained. If there were to be
an automatic contraction of the PFM through contraction of ring
muscles, as Liebergall claims, neither the physiotherapists nor
patients would need training. If, on the other hand, patients must
be trained to achieve a co-contraction of the PFM, then the PFM
must be trained explicitly (in addition to training of the ring
muscles). This makes it impossible to separate whether any effect
of ring muscle training is due to contraction of the ring muscles or
training of the PFM. Resende and colleagues compared the strength
of PFM contractions with and without addition of ring muscle
contraction and found that ring muscle contraction made no
difference.7 Experienced physiotherapists, who followed the
description given in Liebergall’s articles, conducted both experi-
mental studies.
The 2009 trial report5 states ‘The primary outcome was change
in the quantity of urinary leakage’ (page 378). That iswhywe chose
this variable, not self-reported cure, as the reported outcome
measure. Pad testing is a more reliable and valid measurement
than subjective report. We would argue that since an effect of the
Paula method on the secondary subjective outcome cannot be
explained by its theory, there are other more-likely explanations
for these results. For example, the apparent effect could be due to
differences in the training dosage between the two comparison
groups. In both the randomised trials by Liebergall,5,8 the Paula
group had 45 minutes of training perweek plus 15 to 45 minutes ofindividual daily home training for 12 weeks, while the PFM
training group had 30 minutes per week of group training and
15 minutes of daily home training for four weeks (plus calls from
the physiotherapist every second week). This clearly favours the
Paula group (nine hours of individual training and 63 hours of
home training compared with three hours of group training and
21 hours of home training). Furthermore, participants in the Paula
group also received training for the PFM. It is not possible to make
any conclusion about the effectiveness of the Paula method
compared to PFM training based on such a design and content of
the intervention. The main question remains: is the Paula method
more or less effective than PFM training? The primary outcome
implies that the Paula method is less effective. Whether Paula
therapy adds anything to PFM training is another question that
cannot be answered by these two randomised trials.
We wrote that the PFM training program implemented in
Liebergall’s trials was far from optimal. The most problematic
aspect of the PFM training was that the PFM training group
received just 30 minutes of group training perweek for fourweeks.
This is substantially less than the doses used in programs that have
been shown to be effective in rigorous trials (eg, the trial by Bø and
colleagues9). In the trial by Bø and colleagues,9 which Liebergall
cites as an effective PFM training program, the women had weekly
group exercise classes of 45 minutes for six months, with
individual follow-up and clinical assessment of improvement of
PFM function once a month. Liebergall compared Paula therapy
with a program of PFM training that clearly used a lower dosage of
training than what he refers to as effective PFM training.
Our view, based on evidence from high-quality randomised
trials and systematic reviews,10 is that PFM training should be ﬁrst-
line treatment for women with stress urinary incontinence. The
design of such exercise programs should be based on the modes of
exercise and exercise dosages that have shown to be effective in
high-quality randomised trials. There is not yet evidence to suggest
that the Paula method is as effective as PFM training. Until such
evidence is available, PFM training should be the preferred therapy.
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